Search for: "Heritage Pharmaceuticals, Inc."
Results 21 - 40
of 40
Sort by Relevance
|
Sort by Date
14 Sep 2011, 12:07 pm
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
14 Sep 2011, 12:07 pm
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
9 Sep 2011, 8:40 am
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
22 Jun 2011, 7:09 am
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
7 Jun 2011, 12:30 pm
Certiorari stage documents:Opinion below (2d Circuit)Petition for certiorariBrief in opposition of Steinbeck Heritage Foundation/Estate RespondentsPetitioners' replyAmicus brief of Graphic Artists Guild et al.Amicus brief of Penguin Group (USA), Inc. [read post]
4 Apr 2011, 5:10 am
(China Law Blog) Queer eye for the straight blog, or how to spot a counterfeit perfume (China Hearsay) On the state of Intellectual Property in China (China Law Blog) Landmark in China: Law on intangible cultural heritages (TK Community) Europe Global dispute with only local significance: Anheuser-Busch, Inc. v Bud? [read post]
11 Feb 2011, 7:51 am
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
2 Oct 2010, 8:43 am
Peter Rost is a former Pfizer Marketing Vice President providing services as an expert witness on pharmaceutical marketing and consulting services on corporate therapeutics and ethics guidelines. [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
12 Jan 2010, 5:00 am
Novartis Pharmaceuticals Corp., No. [read post]
4 Sep 2009, 12:11 pm
KV Pharmaceutical Company, C.A. 08-223-JJF (D. [read post]
9 Aug 2008, 1:50 am
: (Techdirt), Microsoft Research launches new tools for knowledge sharing: (creativecommons.org), Yet another star singer, Duffy, doesn’t mind file-sharing: (Techdirt) Events 20 August – Bill Patry speaking on copyright – Melbourne: (Patry Copyright Blog), (LawFont.com), 21 August – Bill Patry speaking on copyright – Canberra: (Patry Copyright Blog), (LawFont.com), 22 August – Bill Patry speaking on copyright – Sydney:… [read post]
23 May 2008, 1:28 am
Mike Honda on May 21, 200805/22/2008
Legislative Text of the Kenai Mountains-Turnagain Arm National Forest Heritage Area Act (S. 3045)Text of the Bill as Introduced by Sen. [read post]
9 May 2008, 10:30 pm
, US: ACI ‘In-house counsel forum on pharmaceutical antitrust’ – 20-21 May, Maryland: (Orange Book Blog), EU: Workshop for mediators in IP disputes – 26-27 May, Geneva: (IPR-Helpdesk), US: PLI: ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – 28 May, New York / 11 June, San Francisco: (Patent Docs), US: Worldwide Business Research: PharmaBiotech IP summit –… [read post]
18 Apr 2008, 2:00 am
: RealNetworks, Mattel and Hasbro copy the infringer by creating online Scrabble: (IP ThinkTank), Creative Commons Statement of Intent for Attribution-Share Alike Licenses released: (creativecommons.org) Events IP Business Congress – 25-26 June, Amsterdam: (IP Business Congress), INTA annual meeting – 17-21 May, Berlin: (IMPACT), Australia: IPRIA / CELRL / IP Australia: Employees’ IP and the employment relationship – incentives to innovate… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging… [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
20 Oct 2007, 7:34 am
And the fact is that pharmaceutical companies, in the hopes of getting a big return, spend an average $802 million and 12 years of research and development to bring a new drug to market. [24] Not every endeavor bears fruit, and projects are often discarded along the way. [read post]
8 Mar 2006, 5:12 am
Mylan Pharmaceuticals, Inc. v. [read post]
